SSAC:LSE:LSE-iShares MSCI ACWI UCITS ETF USD (Acc) GBP (GBX)

ETF | Others |

Last Closing

USD 7127

Change

+20.00 (+0.28)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+0.50 (+0.22%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+4.04 (+3.05%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.12 (-0.70%)

USD 562.96B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.04 (-0.27%)

USD 562.96B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-1.05 (-1.67%)

USD 266.08B
0QZO:LSE 0QZO

-1.20 (-1.07%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.20 (-0.70%)

USD 211.57B
0QZ3:LSE Qualcomm Inc.

+5.94 (+3.92%)

USD 202.26B
0R24:LSE Intel Corp.

+0.54 (+2.74%)

USD 196.14B

ETFs Containing SSAC:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.75% 80% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.75% 79% B- 77% C+
Trailing 12 Months  
Capital Gain 20.94% 80% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.94% 79% B- 77% C+
Trailing 5 Years  
Capital Gain 67.93% 82% B 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 67.93% 80% B- 84% B
Average Annual (5 Year Horizon)  
Capital Gain 12.47% 70% C- 72% C
Dividend Return 12.47% 70% C- 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.95% 64% D 79% B-
Risk Adjusted Return 113.88% 96% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike